Drugs causing hyperkalemia
Pro Research Analysisby 
Searched over 200M research papers
Drugs Causing Hyperkalemia: Mechanisms and Risk Factors
Introduction to Hyperkalemia and Drug-Induced Causes
Hyperkalemia, defined as a serum potassium concentration exceeding 5.0 mmol/L, is a common and potentially life-threatening condition. Drug-induced hyperkalemia is a significant cause of elevated potassium levels in clinical practice, often occurring without symptoms but sometimes leading to severe complications1. Understanding the mechanisms by which various drugs induce hyperkalemia and identifying at-risk patient populations are crucial for effective management and prevention.
Mechanisms of Drug-Induced Hyperkalemia
Impaired Renal Potassium Excretion
The most common mechanism by which drugs cause hyperkalemia is through impaired renal potassium excretion. This impairment often results from the inhibition of the renin-angiotensin-aldosterone system (RAAS). Medications such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin-II receptor blockers (ARBs), direct renin inhibitors, and aldosterone antagonists fall into this category1 2 7. Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs), calcineurin inhibitors, heparin, and potassium-sparing diuretics also contribute to reduced renal potassium excretion1 7.
Altered Transmembrane Potassium Movement
Certain drugs can cause hyperkalemia by altering the movement of potassium across cell membranes. Beta-blockers, calcium channel blockers, and suxamethonium are examples of medications that can promote a transcellular shift of potassium, leading to increased serum levels1 7.
Increased Potassium Supply
Drugs that increase the body's potassium supply, such as potassium supplements and potassium-containing agents, can also lead to hyperkalemia. This is particularly concerning in patients with compromised renal function, where the body's ability to excrete excess potassium is already impaired1 3.
Common Drugs Associated with Hyperkalemia
Potassium-Sparing Diuretics and Supplements
Potassium-sparing diuretics, such as spironolactone and eplerenone, and potassium supplements are frequently implicated in hyperkalemia cases. These drugs are often used in patients with conditions like heart failure and chronic kidney disease, who are already at higher risk for hyperkalemia3 6.
RAAS Inhibitors
ACE inhibitors and ARBs are commonly prescribed for hypertension and heart failure but are well-known for their potential to cause hyperkalemia. This risk is heightened in patients with diabetes, chronic kidney disease, or those who are elderly8 9.
NSAIDs and Calcineurin Inhibitors
NSAIDs, such as ibuprofen and naproxen, and calcineurin inhibitors, like cyclosporine and tacrolimus, can impair renal function and reduce potassium excretion, leading to hyperkalemia1 7.
Beta-Blockers and Calcium Channel Blockers
These medications, used for managing cardiovascular conditions, can cause a shift of potassium from the intracellular to the extracellular space, contributing to elevated serum potassium levels1 7.
Risk Factors for Drug-Induced Hyperkalemia
Underlying Health Conditions
Patients with chronic kidney disease, diabetes mellitus, heart failure, and metabolic acidosis are at increased risk for drug-induced hyperkalemia. These conditions affect the body's ability to regulate potassium levels effectively3 6.
Age and Comorbidities
Older adults and patients with multiple comorbidities are more susceptible to hyperkalemia due to decreased renal function and the use of multiple medications that can affect potassium homeostasis6 9.
Combination Therapy
The concurrent use of multiple drugs that impair potassium excretion or increase potassium levels can significantly raise the risk of hyperkalemia. For instance, combining RAAS inhibitors with potassium-sparing diuretics or NSAIDs can be particularly hazardous1 7.
Conclusion
Drug-induced hyperkalemia is a critical concern in clinical practice, especially among patients with underlying conditions that affect potassium handling. Medications that impair renal potassium excretion, alter transmembrane potassium movement, or increase potassium supply are the primary culprits. Recognizing the risk factors and mechanisms involved is essential for preventing and managing hyperkalemia effectively. Regular monitoring and cautious use of these medications can help mitigate the risks associated with drug-induced hyperkalemia.
Sources and full results
Most relevant research papers on this topic
Drug-Induced Hyperkalemia
Drug-induced hyperkalemia can be caused by a wide range of medications, requiring increased awareness and monitoring to prevent hospital admissions, morbidity, and mortality.
Highly CitedDrug-induced hyperkalemia: old culprits and new offenders.
Drug-induced hyperkalemia can develop in patients with underlying renal impairment or abnormalities in potassium handling, and physicians should be aware of medications that may cause this issue.
Highly CitedHyperkalemia as a complication of drug therapy.
Drug therapy contributes to more than 60% of hyperkalemic episodes, with potassium regulation being compromised in over 80% of cases due to underlying diseases.
Literature ReviewHighly CitedManagement of hyperkalemia in the acutely ill patient
Tailoring treatment for hyperkalemia in acutely ill patients should consider both their ability to lower serum potassium levels and their potential side effects, to limit risks.
Systematic Review
Rigorous JournalHighly CitedHyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
Finerenone improves cardiorenal outcomes in patients with CKD and T2D, but is associated with a twofold higher risk of hyperkalemia compared to placebo.
RCT
Large Human TrialHighly CitedDrug‐Induced Hyperkalemia
Drug-induced hyperkalemia remains a significant issue, with new actors like salt substitutes, beta-blockers, and heparin also contributing to the issue.
Highly CitedUniversity of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia.
Drug-induced hyperkalemia is a common issue in clinical practice, and evaluating all potential causes, including drugs, is crucial in preventing complications.
Mechanisms of drug-induced hyperkalemia
Drug-induced hyperkalemia can cause serious health complications, especially in patients with underlying disorders and those taking a combination of drugs known to cause hyperkalemia.
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.
Hyperkalemia can develop as a side effect of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers, especially in patients with risk factors like diabetes, heart failure, chronic kidney disease, or advanced age.
Highly CitedSodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People With Type 2 Diabetes: A Meta-Analysis of Individual Participant Data From Randomized, Controlled Trials
SGLT2 inhibitors reduce the risk of serious hyperkalemia in people with type 2 diabetes at high cardiovascular risk or chronic kidney disease without increasing the risk of hypokalemia.
Meta-AnalysisRigorous JournalHighly Cited